Chronic lymphocytic leukemia with SF3B1 mutation

New England Journal of Medicine

Volumn 366, Issue 26, 2012, Pages 2530-

  Quesada, Victor ^a   Ramsay, Andrew J ^b   Lopez Otin, Carlos ^b  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; PROTEIN KINASE ZAP 70;

CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; GENETIC ASSOCIATION; HUMAN; INCIDENCE; LETTER; MOLECULAR PATHOLOGY; ONCOGENE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SF3B1 GENE; SOMATIC MUTATION; SURVIVAL TIME;

EID: 84862854953     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1204033     Document Type: Letter

References (3)

1. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011;365:2497-506.
2. Mori J, Takahashi Y, Tanimoto T. SF3B1 in chronic lymphocytic leukemia. N Engl J Med 2012;366:1057-8.
3. Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2012;44:47-52.